Basics Vir Biotechnology, Inc. IPO Date: October 11, 2019 Sector: Healthcare Industry: Biotech Market Cap: $732.66M Activated in VL: True Average Daily Range Avg Daily Range: $0.88 | 3.15% Avg Daily Range (30 D): $0.12 | 2.26% Avg Daily Range (90 D): $0.15 | 2.78% Institutional Daily Volume Avg Daily Volume: .97M Avg Daily Volume (30 D): .95M Avg Daily Volume (90 D): 1.05M Trade Size Avg Trade Size (Sh.): 79 Avg Trade Size (Sh.) (30 D): 92 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 3,049 Avg Inst. Trade: $2.47M Avg Inst. Trade (30 D): $1.03M Avg Inst. Trade (90 D): $1.17M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.68M Avg Closing Trade (30 D): $1.01M Avg Closing Trade (90 D): $1.18M Avg Closing Volume: 181.1K     News Jun 6, 2024 @ 5:29 PM Biotech Stock Roundup: GSK's Litigation Update, BI... Source: Zacks Equity Research Jun 6, 2024 @ 5:26 PM Vir Biotechnology (VIR) Up on Positive Data From H... Source: Zacks Equity Research May 24, 2024 @ 5:01 PM Evaluating Vir Biotechnology: Insights From 5 Fina... Source: Benzinga Insights May 7, 2024 @ 1:00 PM Deep Dive Into Vir Biotechnology Stock: Analyst Pe... Source: Benzinga Insights May 2, 2024 @ 10:05 PM Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Top... Source: Zacks Equity Research Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.88 $-1.56 Diluted EPS $-.88 $-1.56 Revenue $ $ 3.03M $ 2.38M Gross Profit $ $ $ 2.33M Net Income / Loss $ $ -120.97M $ -213.72M Operating Income / Loss $ $ -139.55M $ -231.3M Cost of Revenue $ $ M $ .05M Net Cash Flow $ $ 49.3M $ -52.85M PE Ratio